Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Active Not Recruiting NCT07041125

Concomitant LAAC/AF Ablation (Watchman FLX Pro)

Conditions: PFA Ablation and LAAC Procedures

Sex: All
Ages: 18 Years – N/A
Enrollment: 120
Sponsor: Heart Rhythm Clinical and Research Solutions, LLC

Location: Arrhythmia Institute at Grandview Birmingham Alabama

Summary

This sub-study is a prospective/retrospective, non-randomized, observational, comparative cohorts study, embedded in and expanding on the infrastructure of a real-world AF ablation registry DISRUPT-AF (NCT06335082).

Eligibility Criteria

Inclusion Criteria: All inclusion criteria of the main DISRUPT-AF registry will apply. In addition, patients included in this sub study must meet the additional inclusion criteria below: * Patients who are determined by physicians to be eligible for LAAC * Patients whose LAAC with Watchman FLX Pro procedures are performed concomitant following AF ablation procedure * Willing and able to provide additional informed consent to the sub-study (unless waiver of consent is obtained) Exclusion Criteria: All exclusion criteria of the main DISRUPT-AF registry will apply. In addition, patients included in this sub study have the additional exclusion criteria below: -Patients who are participating in other DISRUPT-AF sub-studies

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07041125). StuddyBuddy aggregates publicly available trial information.